Department of Respiratory and Critical Care Medicine, Xuzhou Central Hospital, Xuzhou, China.
Department of Cardiothoracic Surgery, Xuzhou Central Hospital, Xuzhou, China.
Interact Cardiovasc Thorac Surg. 2022 Feb 21;34(3):482-484. doi: 10.1093/icvts/ivab262.
We investigated the efficacy of subxiphoid thoracoscopic thymectomy in patients with myasthenia gravis. The data of 37 consecutive cases were reviewed. 2 cases of postoperative myasthenia gravis crisis and 4 cases of residual mediastinal fat tissue were recorded. Moreover, 29 patients presented the neurological outcomes, and complete stable remission was achieved in 5 (17.2%) cases. Subxiphoid thymectomy is technically feasible. High-quality evidence is warranted before this approach can be recommended.
我们研究了剑突下胸腔镜胸腺切除术治疗重症肌无力的疗效。回顾了 37 例连续病例的数据。记录了 2 例术后肌无力危象和 4 例纵隔脂肪残留。此外，29 例患者出现神经学结果，5 例（17.2%）达到完全稳定缓解。剑突下胸腺切除术在技术上是可行的。在推荐这种方法之前，需要有高质量的证据。
